Cluster headaches device approved by NICE in draft guidance

A handheld device that delivers a small electric current has been recommended by NICE for the prevention and treatment of cluster headaches, a rare but painful type of headache that affects around 100,000 people in the UK. The recommendation is made in NICE’s draft medtech guidance published for public consultation. It highlights that using gammaCore in addition to standard care (sumatriptan, zolmitriptan and oxygen) could save the NHS £450 per patient in the first year compared to standard care alone. The guidance says that, because gammaCore is not effective in all patients with cluster headache, it should only be used